Prevalence and Clinical Significance of Anti-phospholipid Antibodies in Multiple Sclerosis: a Study of 89 Patients

By Roussel V.   Yi F.   Jauberteau M.O.   Couderq C.   Lacombe C.   Michelet V.   Gil R.   Couratier P.   Vallat J.M.   Preud’homme J.L.  

Journal of Autoimmunity, Vol. 14, Iss. 3, 2000-05 ,pp. : 259-265

Academic Press

Access to resources Recommend Favorite

Determination of antibodies to Toxoplasma gondii and CMV in renal transplant recipients

By Iqbal J.   Nampoory M.R.N.   Johnv K.V.   Khalid N.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2703-2705

Elsevier

Access to resources Recommend Favorite

Clinical significance of donor-specific alloantibodies in liver transplant recipients

By Rodrigues H.   Monteiro F.   Massarolo P.   Viggiani C.   Preuhs G.   Panajotopoulos N.   Leitao R.   Mies S.   Raia S.   Kalil J.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2986-2987

Elsevier

Access to resources Recommend Favorite

Malignancy in renal transplant recipients

By Min S.K.   Huh S.   Ahn M.S.   Jung I.M.   Ha J.   Ahn C.   Bang Y.J.   Chung J.K.   Kim S.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1980-1981

Elsevier

Access to resources Recommend Favorite

Lipoprotein(A) in renal transplant recipients

By Fonseca I.   Queiros J.   Costa S.   Santos M.J.   Henriques A.C.   Sarmento A.M.   Guimaraes S.   Pereira M.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 370-372

Elsevier

Access to resources Recommend Favorite